We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$417M
AUM Growth
-$24.5M
Cap. Flow
-$15.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$7.46M
2
LIN icon
Linde
LIN
+$6.13M
3
LOGI icon
Logitech
LOGI
+$3.75M
4
KO icon
Coca-Cola
KO
+$1.49M
5
AMZN icon
Amazon
AMZN
+$990K

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$14.3M
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$7.54M
3
ALC icon
Alcon
ALC
+$5.41M
4
RACE icon
Ferrari
RACE
+$5.16M
5
CNH
CNH Industrial
CNH
+$2.87M

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 15.28%
3 Consumer Discretionary 11.12%
4 Healthcare 10.96%
5 Industrials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AY
426
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$175K 0.04%
5,080
+197
+4% +$7.46K
RGNX icon
427
Regenxbio
RGNX
$633M
$175K 0.04%
4,180
-326
-7% -$11.7K
HYG icon
428
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$175K 0.04%
1,996
VEEV icon
429
Veeva Systems
VEEV
$32.1B
$172K 0.04%
597
-100
-14% -$31.7K
NEO icon
430
NeoGenomics
NEO
$1.74B
$168K 0.04%
3,483
-576
-14% -$26.7K
AVIR icon
431
Atea Pharmaceuticals
AVIR
$389M
$167K 0.04%
4,766
+576
+14% +$16K
BNDX icon
432
Vanguard Total International Bond ETF
BNDX
$82.1B
$166K 0.04%
2,909
BND icon
433
Vanguard Total Bond Market
BND
$158B
$166K 0.04%
1,937
DSL
434
DoubleLine Income Solutions Fund
DSL
$1.22B
$165K 0.04%
9,300
KRC icon
435
Kilroy Realty
KRC
$4.55B
$164K 0.04%
+2,482
New +$167K
CWB icon
436
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.56B
$164K 0.04%
1,924
-224
-10% -$19.3K
SEDG icon
437
SolarEdge
SEDG
$2.53B
$164K 0.04%
618
-6
-1% -$1.63K
MU icon
438
Micron Technology
MU
$997B
$164K 0.04%
2,307
+581
+34% +$43.6K
REGN icon
439
Regeneron Pharmaceuticals
REGN
$70.5B
$163K 0.04%
270
-198
-42% -$123K
PHAT icon
440
Phathom Pharmaceuticals
PHAT
$957M
$162K 0.04%
5,058
+2,221
+78% +$73.8K
LAMR icon
441
Lamar Advertising Co
LAMR
$16.4B
$162K 0.04%
+1,430
New +$157K
LSPD icon
442
Lightspeed Commerce
LSPD
$1.35B
$162K 0.04%
+1,682
New +$167K
VDE icon
443
Vanguard Energy ETF
VDE
$9.91B
$162K 0.04%
2,190
+190
+10% +$13.3K
EMTL
444
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
$161K 0.04%
3,206
-409
-11% -$20.9K
LSI
445
DELISTED
Life Storage, Inc.
LSI
$161K 0.04%
1,401
-13
-0.9% -$1.55K
CPT icon
446
Camden Property Trust
CPT
$11.2B
$160K 0.04%
1,087
+1,077
+10,770% +$158K
CKPT
447
DELISTED
Checkpoint Therapeutics
CKPT
$159K 0.04%
+4,823
New +$143K
MED icon
448
Medifast
MED
$109M
$157K 0.04%
816
-135
-14% -$33.2K
SHV icon
449
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$156K 0.04%
1,414
SHY icon
450
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$156K 0.04%
1,813

Similar funds

Exane Derivatives's Q3 2021 Portfolio in Review

As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.

  • Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
  • Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
  • Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
  • Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
  • Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
  • Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
  • Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.